InvestorsHub Logo
Followers 20
Posts 5488
Boards Moderated 0
Alias Born 01/04/2012

Re: re-actor post# 12055

Tuesday, 02/21/2012 4:49:57 PM

Tuesday, February 21, 2012 4:49:57 PM

Post# of 26138
In addition it is not the same type of product.

An oral enteric formulation acting on the central nervous system (CNS) with therapeutic characteristics that benefit sufferers of sexual health disorders. It is intended as a treatment for HSDD both as a standalone and as an adjunct to testosterone therapy for the disorder.

It does nothing for testosterone replenishment or CV benefits which has been identified by Libigel. And a along way off.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.